Drug-coated balloon for a new coronary artery blockage
Part of Heart & circulation clinical trials.
This trial studies whether a drug-coated balloon can treat a brand-new (de novo) blockage in the coronary arteries. If you may qualify, it could offer a way to reduce problems from this blockage using a device that delivers medicine during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a brand-new (not previously treated) coronary artery blockage
- Your blood pressure and circulation are stable right now (not unstable)
- Your doctors expect you to live at least 1 year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.
This trial compares two treatments for new blockages in heart arteries: a drug-coated balloon (a tiny balloon that delivers medicine) versus a drug-eluting stent (a small mesh tube that releases medicine). The study hopes to see which approach keeps the artery open longer and is safer over time.
This trial is testing a special balloon coated with medication to treat newly formed blockages in the heart's arteries. The medication may help keep the artery open after the balloon opens it during a standard procedure.
This study looks at how well drug-coated balloons work in real life for people with coronary artery disease. These balloons deliver medicine to open blocked heart arteries, and this trial aims to see how they perform in different patients.
This trial tests a special balloon that releases medicine to open blocked heart arteries. It may help people with chest pain or silent ischemia by keeping arteries open longer.
This trial studies whether a drug-coated balloon can treat certain coronary artery narrowings in adults with chronic (long-term) coronary disease. It may help prevent re-narrowing after the procedure for people whose tests show the blockage is significant and needs treatment.
Hear when a new Drug Coated Balloon trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.